Vetigenics Announces Publication of Comprehensive Preclinical Data for Anti-Canine CTLA4 Monoclonal Antibody

Published study confirms validity of the first entirely canine phage display technology to generate unique canine immunotherapy for treating canine cancer.

Read More

.elementor-icon, a.skip-link{display:none!important;} .print-img img{margin:0 auto!important} .elementor-element-23751c5 img.attachment-full {max-width:100%!important} .dogs.print-no{display:none!important;} .print-text-align-center{text-align:center!important;} img.attachment-full.size-full.wp-image-1769.pf-large-image.pf-primary-img.flex-width.pf-size-small.mediumImage { display: none!important; }